13th Annual Biotech and Specialty Pharmaceuticals Conference
December 1, 2009
The major biotech indexes are either matching or outperforming the S&P 500. At the beginning of October, the Nasdaq Biotech Stock Index (NBI) was up nearly 10% YTD and the AMEX Biotech Index (BTK) had gains of almost 40%. The S&P 500 was up approximately 10%.
The CEOs, CFOs, and other executives from some of the industry’s most innovative small- and micro-cap companies will discuss their plans to invent, develop, research, and market important new drugs, diagnostics, and delivery technologies.
Click here for more information and to register.
|
